CDNA
CareDx, Inc.
Key Financials
Gross Profit
$81.6M
↑ 87.3%
Operating Income
$-30781000
↓ 175.5%
EPS (Diluted)
$-0.40
↓ 143.0%
Net Income
$-21354000
↓ 140.6%
Total Assets
$413.2M
↓ 15.8%
Total Liabilities
$110.1M
↓ 2.2%
Shareholders' Equity
$303.1M
↓ 19.9%
Cash & Equivalents
$65.4M
↓ 43.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 6/30/2026 | View on SEC |
| 144 | 6/29/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CDNA |
| Company Name | CareDx, Inc. |
| CIK | 1217234 |
| Sector | Services-Medical Laboratories |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 415-287-2300 |